High TDP43 expression is required for TRIM16-induced inhibition of cancer cell growth and correlated with good prognosis of neuroblastoma and breast cancer patients-Reference-Cited by-同舟云学术

High TDP43 expression is required for TRIM16-induced inhibition of cancer cell growth and correlated with good prognosis of neuroblastoma and breast cancer patients

Published:2016-05 Issue:2 Volume:374 Page:315-323
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Kim Patrick Y.,Tan Owen,Liu Bing,Trahair Toby,Liu Tao,Haber Michelle,Norris Murray D.,Marshall Glenn M.,Cheung Belamy B.^ORCID

Funder

National Health and Medical Research Council

Cancer Institute NSW

Cancer Council NSW

Australia Postgraduate Research Award

UNSW

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference35 articles.

1. TRIM proteins and cancer;Hatakeyama;Nat. Rev. Cancer,2011

2. Structural basis for PRYSPRY-mediated tripartite motif (TRIM) protein function;James;Proc. Natl. Acad. Sci. U.S.A.,2007

3. Crystal structure of PRY-SPRY domain of human TRIM72;Park;Proteins,2010

4. The estrogen-responsive B box protein is a novel regulator of the retinoid signal;Cheung;J. Biol. Chem,2006

5. The retinoid signalling molecule, TRIM16, is repressed during squamous cell carcinoma skin carcinogenesis in vivo and reduces skin cancer cell migration in vitro;Cheung;J. Pathol,2012

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TRIM16 mitigates impaired osteogenic differentiation and antioxidant response in D-galactose-induced senescent osteoblasts;European Journal of Pharmacology;2024-09

2. Insights into Dysregulated Neurological Biomarkers in Cancer;Cancers;2024-07-27

3. The TDP‐43/TP63 Positive Feedback Circuit Promotes Esophageal Squamous Cell Carcinoma Progression;Advanced Science;2024-07-18

4. Emerging roles of tripartite motif family proteins (TRIMs) in breast cancer;Cancer Medicine;2024-07

5. Tripartite motif family – its role in tumor progression and therapy resistance: a review;Current Opinion in Oncology;2024-01-16